Blog
RSS FeedPosted by Michael Wonder on 05 Nov 2021
Drug Utilisation Sub-Committee outcome statement
5 November 2021 - The Outcome Statement from the October 2021 Drug Utilisation SubCommittee meeting is now available. ...
Posted by Michael Wonder on 28 Oct 2021
Mallinckrodt and Terumo Blood and Cell Technologies announce positive recommendations in Australia for public funding of Uvadex (methoxsalen) for ECP administration with the Therakos Cellex photopheresis system for chronic graft versus host disease in adults
28 October 2021 - In a dual review process, two independent advisory committees to the Australian Minister for Health recommended reimbursement ...
Posted by Michael Wonder on 17 Oct 2021
Recommendations made by the PBAC – September 2021 intracycle meeting
15 October 2021 - First PBAC recommendation for a new gene therapy. ...
Posted by Michael Wonder on 15 Oct 2021
Recommendations made between March 2021 and November 2021 PBAC meetings
15 October 2021 - Recommendations made by the PBAC between the March 2021 and November 2021 have been published. ...
Posted by Michael Wonder on 20 Aug 2021
Recommendations made by the PBAC – July 2021
20 August 2021 - Recommendations made by the PBAC in July 2021 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 05 Jul 2021
PBAC Public Summary Document for risdiplam – March 2021 meeting
5 July 2021 - The Public Summary Document for risdiplam from the March 2021 PBAC meeting is now available. ...
Posted by Michael Wonder on 18 Jun 2021
Outcomes of the May 2021 PBAC intracycle meeting
18 June 2021 - The outcomes from the May 2021 PBAC meeting are now available. ...
Posted by Michael Wonder on 12 May 2021
Agenda items scheduled for review by the PBAC under the process for reviewing recommendations not accepted by applicants
13 May 2021 - The revised agenda for the July 2021 PBAC meeting notes seven medicines/medicinal preparations for review under ...
Posted by Michael Wonder on 23 Apr 2021
Outcomes from the March 2021 PBAC meeting
23 April 2021 - The outcomes from the March 2021 PBAC meeting are now available. ...
Posted by Michael Wonder on 22 Mar 2021
PBAC publishes sham Public Summary Document for upadacitinib
22 March 2021 - The outcome section makes absolutely no reference to the issue at hand. ...
Posted by Michael Wonder on 08 Mar 2021
Department of Health publishes Public Summary Document for medicine without a published outcome
8 March 2021 - The Department of Health has published a Public Summary Document for mometasone furoate with indacaterol maleate ...
Posted by Michael Wonder on 07 Mar 2021
Where is the corrigenda?
8 March 2021 - Can the Department of Health simply ignore PBAC advice? ...
Posted by Michael Wonder on 05 Mar 2021
PBAC Public Summary Documents - November 2020 meeting
5 March 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2020 PBAC ...
Posted by Michael Wonder on 15 Feb 2021
Post-market review of medicines for smoking cessation – stakeholder forum outcome
15 February 2021 - A stakeholder forum was held for the post-market review of medicines for smoking cessation via webinar on ...
Posted by Michael Wonder on 29 Jan 2021
Recommendations made by the PBAC - December 2020 Intracycle meeting
29 January 2021 - The recommendations from the December 2020 PBAC meeting are now available. ...